Markets›Health care›BSX

Boston Scientific

BSX
43.92
-0.76 (-1.70%)
Closing price for Sep 25, 2026 from Polygon.io
Income statement Balance sheet Cash flow | Annual Quarterly |Download CSV
Balance sheet (USD) Q2 2026
ended Jun 30, 2026
Q1 2026
ended Mar 31, 2026
Q4 2025
ended Dec 31, 2025
Q3 2025
ended Sep 30, 2025
Q2 2025
ended Jun 30, 2025
Q1 2025
ended Mar 31, 2025
Q4 2024
ended Dec 31, 2024
Q3 2024
ended Sep 30, 2024
Cash and equivalents 539.00M1.45B1.97B1.27B534.00M725.00M414.00M2.50B
Inventory 3.23B3.12B2.94B2.92B2.86B2.87B2.81B2.75B
Total current assets 7.97B8.68B8.79B8.04B7.12B7.33B6.92B8.76B
Property, plant and equipment 4.13B4.06B4.04B3.79B3.46B3.39B3.29B3.07B
Goodwill and intangibles 25.56B25.60B25.30B25.38B25.34B23.91B23.77B20.79B
Total assets 45.22B44.35B43.67B42.71B41.56B40.14B39.40B38.08B
Accounts payable 1.23B1.14B1.14B1.00B962.00M1.00B960.00M907.00M
Total current liabilities 6.43B4.57B5.44B5.33B5.19B5.06B6.40B5.91B
Long-term debt 10.91B10.99B11.14B11.12B11.11B10.53B8.97B9.23B
Total liabilities 20.29B18.49B19.44B19.31B19.14B17.93B17.63B17.37B
Retained earnings 7.82B6.91B5.57B4.90B4.14B3.35B2.67B2.11B
Shareholders' equity 24.93B25.86B24.23B23.39B22.42B22.21B21.77B20.71B
Total debt 12.62B11.03B11.44B11.60B11.59B11.31B10.75B10.88B
Net debt 12.09B9.58B9.47B10.32B11.05B10.58B10.33B8.38B

From Boston Scientific's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.

Charts

Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.